How many FDA warning letters has Eugia Pharma Specialities Limited received?

Argus HQ has not recorded an FDA warning letter for Eugia Pharma Specialities Limited in our current dataset.

What FDA recalls has Eugia Pharma Specialities Limited issued?

Argus HQ has not recorded an FDA recall tied to Eugia Pharma Specialities Limited in our current dataset.

Is Eugia Pharma Specialities Limited FDA compliant?

Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 0 recalls, and 0 approval records for Eugia Pharma Specialities Limited. Review the linked FDA source records directly before drawing a compliance conclusion.

.hq

company

Eugia Pharma Specialities Limited

Name: FDA Enforcement Actions Against Eugia Pharma Specialities Limited
Creator: Argus HQ
License: https://argushq.ai/methodology

Jurisdiction: US

FDA Warning Letter timeline

V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.

fda_483 · inspection_citation2026-02-27
Eugia Pharma Specialities Limited -- FDA 483: 4 observations (2026-02-27)
fda_483 · inspection_citation2026-02-06
Eugia Pharma Specialities Limited -- FDA 483: 1 observation (2026-02-06)

Frequently asked questions

How many FDA warning letters has Eugia Pharma Specialities Limited received?: Argus HQ has not recorded an FDA warning letter for Eugia Pharma Specialities Limited in our current dataset.
What FDA recalls has Eugia Pharma Specialities Limited issued?: Argus HQ has not recorded an FDA recall tied to Eugia Pharma Specialities Limited in our current dataset.
Is Eugia Pharma Specialities Limited FDA compliant?: Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 0 recalls, and 0 approval records for Eugia Pharma Specialities Limited. Review the linked FDA source records directly before drawing a compliance conclusion.

Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.